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1. Introduction
Malaria is one of the most dangerous tropical parasitic diseases.
About 198 million cases of malaria infection and an estimated 584 
million deaths were reported in 2013, mostly among children living 
in Africa where almost one child dies every minute[1]. It also poses 
a risk to travellers and immigrants, with imported cases increasing 
in non-endemic areas[2]. Therefore, endemic countries started to 
adopt artemisinin-based combination therapies for uncomplicated 
malaria[3]. However, in the Greater Mekong Subregion, Plasmodium 
falciparum (P. falciparum) has become resistant to almost all 
available antimalarial medicines. In addition, there is a real risk 
that multidrug resistance will emerge soon in other parts of the 
subregion as well[4]. Therefore, the current research aimed at the 
development of new antimalarial agents.
   The genus Atriplex comprises of 200 species and belongs to the 
subfamily Chenopodiaceae. Although this genus is considered as 
common weeds, it has always been used as folk remedy. In the 
Arab world, Atriplex halimus is used as a laxative, stomach pain 
killer, against intestinal worms, to regulate gall bladder excretions 
and to treat chest ailments. The Bedouin tribes in the Negev use the 
plant for treating muscular pain and intestinal diseases in animals, 
to feed sheep and goats, and to flavor cooking. The leaves are 
edible but too salty to be eaten alone[5]. The chemical composition 
of Atriplex species is very complicated as it contains flavonol as 
the major components[6,7], triterpene saponins[8,9], alkaloids and 
amino acids[10], coumarins and ecdysterols[11]. Therefore, Atriplex 
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species have been reported as cytotoxic[9,12], antimicrobial[13], 
antioxidant[14], antidiabetic[15], and to reduce male fertility in 
rats[11].
   Of the Atriplex species, Atriplex lindleyi Moq. (A. lindleyi) 
synonym: Atriplex halimoides, known as Lindley’s saltbush, is 
widely spread in Egypt, especially in dry areas. The hepatorenal 
protective potential of Lindley’s saltbush was evaluated[16], and its 
antidiabetic, antihepatotoxic, antimicrobial and anti-inflammatory 
activities were reported[17,18]. In addition, several compounds were 
isolated such as flavonoids, quercetin, quercetrin, isoquercetin 
and isorhamnetin-3-O-glucopyranoside besides lupeol, ecdesterol, 
3,23-dihydroxybetulin, 20-hydroxyecdysone,olean-12-en-3,11-
dione, β-amyrenone, erythrodiol and cholesterol[16-18]. The present 
work deals with the identification of phenolic constituents and 
the investigation of the antiplasmodial, antimicrobial and radical 
scavenging effect of A. lindleyi extracts.
2. Materials and methods
2.1. General experiment 
   Ultraviolet spectra were recorded by using UV-vis double beam 
UWD-3500 spectrophotometer (Labomed, Inc. USA). Electrospray 
ionization mass (ESIMS) was obtained from an LCQ Advantage 
Thermo/Finnigan spectrometer (Thermo Finnigan, USA). Nuclear 
magnetic resonance (NMR) spectra were measured on JEOL EX-
500 spectrometer (Tokyo, Japan) with 500 MHz for 1H-NMR and 
125 MHz for 13C-NMR by using methyl sulfoxide-d6 as solvent and 
as internal reference. Analytical thin layer chromatography (TLC) 
was done on TLC cellulose and silica gel 60 F254 (200 mm layer 
thickness) (Merck; Darmstadt, Germany). Chromatograms were 
visualized under UV light at 366 nm before and after sprays of 
aluminium chloride reagent. 
   The phenolic acids were analyzed by using high performance 
liquid chromatography (HPLC), HPLC Agilent 1100 series 
(Waldbornn, Germany), equipped with quaternary pump (G1311A), 
degasser (G1322A); the column used was Zorbax 300SB C18 
(Agilent Technologies, USA). Injection was carried out at wave 
length of 280 nm for separation of phenolic compounds. Reference 
compounds were purchased from Sigma-Aldrich (Steinheim, 
Germany), and column chromatography for fractionation was 
employed by using Polyamide 6S (Riedel-de-Haen AG, Seelze 
Haen AG, D-30926 Seelze Hanver, Germany). The purification was 
performed on Sephadex LH-20 (Pharmacia, Sweden) column. All 
chemicals of analytical grade were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). Solvents were purchased from Merck 
(Darmstadt, Germany). 
2.2. Plant material
A. lindleyi Moq. aerial parts were collected in March from Road
of Suez, Egypt. A voucher specimen (No. 954) was kept in the 
Herbarium of National Research Centre.
2.3. Extraction and isolation  
   Dried powdered aerial parts of A. lindleyi (350 g) were 
successively extracted with petroleum ether (40–60 °C), chloroform 
and 70% aqueous ethanol (23.0, 12.5 and 12.0 g), respectively. 
The aqueous ethanol extract was subjected to reversed phase 
liquid chromatography on polyamide eluted with water gradient 
and decreased polarity with methanol. Fractions of 100 mL were 
collected and monitored on TLC silica plates by using ethyl acetate: 
formic acid: acetic acid: water (100:11:11:27 v/v/v/v) as developing 
solvent. To obtain three substantial fractions, major compounds 
were isolated and purified on Sephadex LH20 subcolumn. Purity of 
isolated compounds was inspected through two-dimensional TLC 
cellulose plates eluted with solvent systems: (1) 15% HOAc (water: 
acetic acid 85:15 v/v), (2) BAW (butanol: acetic acid: water 4:1:5 v/
v/v, upper layer).
2.4. Acid hydrolysis
   Acid hydrolysis was performed by using 6% aqueous hydrochloric 
acid at 100 °C for 2 h. For aglycone detection, the final mixture was 
extracted with ethyl acetate, then the aqueous layer was neutralized 
for determination of the released sugar moiety by using silica gel 
plates with the mixture of n-propanol: ethyl acetate: water (7:2:1 v/v/
v); aniline phthalate was employed as a spray for color detection of 
the sugars[19]. 
2.5. Characterizations of compounds
   Characterizations of compound 1 were UV (λmax) nm: (MeOH): 
257, 269sh, 299sh, 378; (+NaOMe): 291, 367, 456; (+AlCl3): 277, 
302sh, 436; (+AlCl3/HC1): 274, 297, 360sh, 403; (+NaOAc): 286, 
375, 426; (+NaOAc/H3BO3): 261, 384; ESIMS (-ve) m/z: 741 [M-H]-, 
609 [M-H-132]-, 489 [M-H-132-120]-, 301 [M-H-132-308]-.
   Characterizations of compound 2 included UV (λmax) nm: (MeOH): 
257, 269sh, 299sh, 358; (+NaOMe): 272, 327, 410; (+AlCl3): 274, 
303sh, 433; (+AlCl3/HC1): 271, 299, 364sh, 403; (+NaOAc): 271, 
325, 393; (+NaOAc/H3BO3): 262, 299, 387; 
1H-NMRδ: 12.64 (1H, 
s, 5-OH), 7.54 (1H, d, J = 2.5 Hz, H-2'), 7.53 (1H, dd, J = 8.5, 
2.5 Hz, H-6'), 6.83 (1H, d, J = 8.5 Hz, H-5'), 6.36 (1H, d, J = 2.5 
Hz, H-8), 6.15 (1H, d, J = 2.5 Hz, H-6'), 5.33 (1H, d, J = 6.8 Hz, 
H-1''), 5.2 (1H, d, J = 7.6 Hz, H-1'''); 13C-NMRδ: 157.9 (C-2), 133.7
(C-3), 177.8 (C-4), 161.7 (C-5), 99.2 (C-6), 164.9 (C-7), 94.1 (C-8),
157.2 (C-9), 104.3 (C-10), 122.1 (C-1'), 115.8 (C-2'), 145.3 (C-3'),
149.1 (C-4'), 115.6 (C-5'), 121.5 (C-6'), 103.2 (C-1''), 74.4 (C-2''),
76.8 (C-3''), 70.5 (C-4''), 77.3 (C-5''), 67.8 (C-6''), 101 (C-1'''), 70.9
(C-2'''), 72.9 (C-3'''), 70.9 (C-4'''), 65.4 (C-5'''). ESIMS (-ve) m/z: 595
[M-H]-.
 Characterizations of compound 3 were as follows: ESIMS (-ve) 
m/z: 609 [M-H]-, 447 [M-H-glucose]-, 463 [M-H-rhamnose]-, 301 
[M-H-glucose-rhamnose]-; 1H-NMRδ: 12.64 (1H, s, 5-OH), 7.62 (1H, 
d, J = 2.5 Hz, H-2'), 7.60 (1H, dd, J = 8.5, 2.5 Hz, H-6'), 6.85 (1H, 
d, J = 8.5 Hz, H-5'), 6.80 (1H, d, J = 2.5 Hz, H-8), 6.43 (1H, d, J 
= 2.5 Hz, H-6), 5.49 (1H, d, J = 6.9 Hz, H-1'), 5.55 (1H, s, H-1''), 
1.12 (3H, d, J = 6.0 Hz, -CH3); 13C-NMRδ: 156.8 (C-2), 133.7 (C-3), 
177.7 (C-4), 160.9 (C-5), 99.5 (C-6), 161.7 (C-7), 94.4 (C-8), 156.8 
(C-9), 105.7 (C-10), 121.8 (C-1'), 115.3 (C-2'), 145.0 (C-3'), 148.9 
(C-4'), 116.4 (C-5'), 121.1 (C-6'), 100.8 (C-1'), 74.2 (C-2'), 76.6 
(C-3'), 70.3 (C-4'), 77.8 (C-5'), 61.1 (C-6'), 99.5 (C-1''), 70.0 (C-2''), 
70.2 (C-3''), 71.7 (C-4''), 69.9 (C-5''), 18.0 (C-6'').   
   Characterizations of compound 4 were UV (λmax) nm: (NaOMe): 
269, 400; (AlCl3): 275, 330sh, 433; (AlCl3 + HCl): 269, 300sh, 
360sh, 400; (NaOAc): 262, 408 and (NaOAc + H3BO3): 260, 378; 
ESIMS (-ve) m/z: 595 [M-H]-, 463 [M-H-arabinose]-, 301 [M-H-
glucose-arabinose]-.
   Characterizations of compound 5 included UV (λmax) nm: (MeOH): 
271, 338; 1H-NMRδ: 8.02 (2H, d, J =8.5 Hz, H-2', 6'), 6.91 (2H, d, J 
= 8.65 Hz, H-3', 5'), 6.81 (1H, s, H-3); 6-C-β-Glc: 4.73 (1H, d, J = 
9.8 Hz, H-1ʹʹ); 8-C-α-Ara: 4.83 (1H, d, J = 9.7 Hz, H-1ʹʹʹ); 13C-NMRδ: 
182.3 (C-4), 163.6 (C-2), 161.2 (C-7), 161.2 (C-5), 160.8 (C-4ʹ), 
153.4 (C-9), 128.8 (C-2ʹ, 6ʹ), 121.3 (C-1ʹ), 116.0 (3ʹ, 5ʹ), 109.3 (C-6), 
103.7 (C-8), 103.0 (C-10), 102.5 (C-3); 6-C-β-Glc: 74.3 (C-1), 68.4 
(C-2), 79.4 (C-3), 70.3 (C-4), 79.0 (C-5), 60.8 (C-6); 8-C-α-Ara: 
74.9 (C-1), 69.8 (C-2), 73.7 (C-3), 70.0 (C-4), 70.3 (C-5). ESIMS (m/
z): 563 [M-H]-, 473 [M-90]-, 443 [M-120]-, 383 [M-180]-, 353 and 
297.
 Compound 6 was observed in yellow fluorescence under UV 
at λ 360 nm. Its characterizations were as follows: UV (λmax) nm: 
(MeOH): 259, 267sh, 378; (+NaOMe): 291, 241sh, 367, 456; 
(+AlCl3): 275, 259sh, 332sh, 439; (+AlCl3/HCl): 271, 300sh, 363, 
426; (+NaOAc): 286, 375, 426; (+NaOAc/H3BO3): 261, 289, 384; 
ESIMS (-ve) m/z: 463 [M-H]-, m/z 301 [M-H-162]-; 1H-NMRδ: 12.60 
(1H, s, 5-OH), 7.29 (1H, d, J = 1.5 Hz, H-2ʹ), 7.24 (1H, d, J = 8.4 
Hz, H-6ʹ), 6.85 (1H, d, J = 8.4 Hz, H-5ʹ), 6.36 (1H, br s, H-8), 6.19 
(1H, brs, H-6), 5.10 (1H, d, J =7.7 Hz, H-1ʹʹ); 13C-NMRδ: 147.9 
(C-2), 134.6 (C-3), 181.2 (C-4), 161.8 (C-5), 99.3 (C-6), 160.1 (C-7), 
94.1 (C-8), 157.7 (C-9), 104.4 (C-10), 121.6 (C-1ʹ), 115.9 (C-2ʹ), 
145.7 (C-3ʹ), 149.0 (C-4ʹ), 116.1 (C-5ʹ), 121.2 (C-6ʹ), 100.2 (C-1ʹʹ), 
74.5 (C-2ʹʹ), 77.6 (C-3ʹʹ), 71.3 (C-4ʹʹ), 75.4 (C-5ʹʹ), 65.8 (C-6ʹʹ).
   Characterizations of compound 7 were UV (λmax) nm: (MeOH): 
252, 266sh, 352; (+NaOMe): 270, 330, 416; (+AlCl3): 262, 298sh, 
400; (+AlCl3/HC1): 262, 299, 366sh, 400; (+NaOAc): 274, 325, 394; 
(+NaOAc/H3BO3): 254, 268, 356; ESIMS (-ve) m/z: 477 [M-H]-, 300 
[M-H-glucose-CH3]-; 1H-NMRδ: 6.19 (1H, d, J = 2.0 Hz, H-6), 6.39 
(1H, d, J = 2.0 Hz, H-8), 6.89 (1H, d, J = 8.0 Hz, H-5ʹ), 7.57 (1H, 
dd, J = 2.0 and 7.5 Hz, H-6ʹ), 8.02 (1H, d, J = 2.0 Hz, H-20), 3.95 
(3H, s, OMe), 5.32 (1H, d, J = 7.6 Hz, H-1ʹʹ).
   Characterizations of compound 8 included ESIMS (-ve) m/z 301 
[M-H]-; 1H-NMRδ: 6.17 (1H, d, J = 2.0 Hz, H-6), 6.37 (1H, d, J = 
2.0 Hz, H-8), 6.87 (1H, d, J = 8.0 Hz, H-5ʹ), 7.62 (1H, dd, J = 2.0, 
7.5 Hz, H-6), 7.73 (1H, d, J = 2.0 Hz, H-2ʹ).
2.6. HPLC of phenolic acids
   To prepare the fraction containing phenolic compounds, one gram 
of the aqueous ethanol extract was re-extracted with normal butanol 
in separating funnel, and the butanol fraction was evaporated. 
The residue was re-dissolved in methanol, then shaken with ether, 
allowed to stand. Finally, the supernatant was filtered, dried and 
subjected to HPLC as described above, by using mobile phase and 
acetonitrile: phosphate buffer (86:14 v/v) at flow rate of 1 mL/min.
2.7. Antiplasmodial assay  
   Antiplasmodial activity was tested according to the protocol 
previously reported[20]. Roswell Park Memorial Institute 1640 
medium [BioWhittaker, Cambrex (catalogue No. BE12-702F), 
Belgium] containing L-glutamine (BioWhittaker, catalogue No. 
BE17-605E), 25 mmol/L 2-[4-(2-hydroxyethyl)piperazin-1-yl]
ethanesulfonic acid (BioWhittaker, catalogue No. 17-737F), and 
10% human serum (Etablissement Français du Sang, Toulouse, 
France), was used to cultivate P. falciparum. Human red blood cells 
(RBCs) (group O ±) were obtained from Etablissement Français du 
Sang. They were extensively washed with Roswell Park Memorial 
Institute medium to remove plasma and leucocytes. Leucocyte-
free erythrocytes were stored at 50% hematocrit for a maximum 
period of 21 days. P. falciparum asexual blood-stage parasites were 
propagated by incubation at 37 °C in P. falciparum culture media 
at 3%–5% hematocrit in a controlled atmosphere (5% CO2, 100% 
relative humidity). 
   Parasitized RBCs were maintained in 25 cm2 culture flasks (TPP, 
Switzerland, reference No. 90025). Reference drugs, chloroquine 
and artesunate were obtained from Sigma (reference No. C6628) 
and Cambrex, respectively. Chloroquine was dissolved in culture 
medium and artesunate in ethanol (stock solutions of 10 mg/mL) 
and stored at -20 °C before tested. For extract assays, serial extract 
dilutions were made in P. falciparum culture media and added to 
96-well (TPP) culture plates. Plasmodium-infected RBCs were
distributed at 2% parasitaemia (2% hematocrit) in 96-well microtiter
plates with different drug concentrations and incubated for 48 h at 37
°C and 5% CO2.
   [3H]-Hypoxanthine (Perkin-Elmer) was added 24 h after the 
beginning of the incubation. At the end of incubation (48 h), microtiter 
plates were frozen and thawed, and each well was harvested onto a 
glass-fiber filter paper. The quantity of incorporated [3H]-hypoxanthine 
was determined with a β-counter (1450-Microbeta Trilux, Wallac-
PerkinElmer). Growth-inhibition percentages were plotted as a semi-
logarithmic function of drug concentration. The IC50 values were 
determined by linear regression analysis on the linear segments of 
the curves. Assays were repeated three times for each concentration. 
Controls were carried out to assess the background (negative control) 
and parasite growth (positive control).
2.8. Antimicrobial assays 
   Antimicrobial activity was tested according to the method 
previously reported[20]. The extracts were dissolved in water/
dimethylsulfoxide (DMSO) to obtain an initial concentration of 
1 000 µg/mL. The resulting solutions were then diluted in microtiter 
plates in trypcase soja medium (Biomérieux, Craponne, France) 
for bacteria and Sabouraud (Biomérieux, Craponne, France) for 
fungi and yeast. Gram-positive strains, Staphylococcus aureus (S. 
aureus) CIP 4.83 and Enterococcus hirae (E. hirae) CIP 5855, and 
Gram-negative strains, Pseudomonas aeruginosa (P. aeruginosa) 
CIP 82118 and Escherichia coli CIP 53126, were used for the 
antimicrobial assays. For the antifungal assay, cultures of the yeast 
C. albicans IP 48.72 and mould Aspergillus niger (A. niger) IP
1431.83 were employed. Strains were obtained from the collection
of the Pasteur Institute (Paris, France). Microbial suspensions were
prepared in sterile distilled water to obtain final inoculums of 106
cells/mL and 105 spores/mL for bacteria and fungi, respectively.
 Minimal inhibitory concentrations (MICs) and minimal germicidal 
concentrations [(minimum bactericidal concentration (MBC) or 
minimum fungicidal concentration (MFC)] were determined after 
incubation of the bacterial strains at 37 °C and the fungal strains 
at 22.5 or 30.0 °C for 24 h (36 h for A. niger) in the presence of 
serial dilutions of the test compounds. The MIC was defined as 
the concentration of compound at which no macroscopic sign of 
cellular growth was detected in comparison to the control without 
antimicrobial compound. The MBC/MFC was determined by sub-
cultivation on corresponding agar plates after incubation of the 
bacterial strains at 37 °C for 24 h and fungal strains at 22.5 or 30.0 
°C for 48 h. 
   MBC/MFC was defined as the concentration of compound at 
which no macroscopic sign of cellular growth was detected in 
comparison to the control without antimicrobial compound on 
subculturing. All the experiments were carried out in duplicate at 
each concentration. In order to ensure that DMSO per se did not 
interfere with the antimicrobial activity evaluation of the products 
under assay, a control test was also performed containing inoculated 
broth supplemented with only DMSO at the same dilutions used in 
our experiments. 
2.9. 2,2-diphenyl-1-picrylhydrazyl assay 
   The antioxidant activity was evaluated by using the method 
previously reported[20]. The stable 2,2-diphenyl-2-picrylhydrazyl 
nitrogen-centered free radical (DPPH•). DPPH in ethanol (300 µmol/
L, 100 µL) was added to 200 µL of the test compounds at different 
concentrations in the appropriate solvents (MeOH, EtOH, MeOH/
H2O 2:1, v/v). Each mixture was then mixed thoroughly and the 
absorbance was recorded every 5 min for 30 min, by using a 
microplate reader (UV Max, Molecular Devices). The decrease in 
DPPH• absorbance (at λ 530 nm) was monitored. DPPH• solution (100 
µL) in the respective solvent (200 µL) served as the blank. 
 All tests were performed in triplicate. The radical scavenging 
activity of the samples (antioxidant activity) was expressed in 
terms of IC50 (concentration in mg/L required for a 50% decrease 
in DPPH• absorbance). A plot of absorbance vs. concentration was 
made to establish the standard curve and to calculate the IC50. 
Ascorbic acid and Trolox (water-soluble form of vitamin E) were 
used as positive controls. 
3. Results
3.1. Column chromatography
   Column chromatography of aqueous ethanol extract afforded 
eight flavonoids, namely, quercetin-7-O-arabinoside-3-O-
neohesperidosides (1), quercetin-3-O-arabinopyranosyl(1→6)-
glucopyranoside (2), quercetin-3-O-glucopyranoside-7-O-
rhamnopyranoside (3), quercetin-3-O-glucoside,7-O-arabinose (4), 
schaftoside (5), quercimeritrin (6), isorhamnetin-3-O-glucoside (7) 
and quercetin (8). Their structural elucidation was established by 
comparing the UV, ESIMS and/or NMR spectral data with reference 
data from available literature[21-23]. While the absolute configuration of 
the sugar was elucidated through chemical degradation and comparison 
with an authentic standard. To the best of our knowledge, compounds 
1-6 were isolated from A. lindleyi aerial parts for the first time.
   In the case of compound 1, the negative mode ESI of compound 
1 showed molecular ion at m/z 741 [M-H]-. The MS data showed 
fragment ion at m/z 609 [M-H-132]-, 489 [M-H-132-120]-, and 
301 [M-H-132-308]-, indicating successive elimination of pentose, 
rhamnose and hexose, respectively. In addition, fragment ion at m/
z 308 was indicative of compound having the disaccharide structure, 
rutinose or neohesperidose linked through an -O-glycosidic bond. 
The fragmentation patterns of flavonoid O-neohesperidosides were 
more complicated in comparison with their rutinoside analogues. 
A major difference was found in the [M-H-120]- ion in the MS2 
spectrum, which was a common feature of all the flavonoid 
O-neohesperidosides[24]. The low intensity of fragment ion m/
z 609 due to loss of pentose indicates its position at C7[21,25]. The 
chromatographic behavior and UV supported a 3,7-glycosylated 
flavonolstructure. Additional confirmation was obtained by acid 
hydrolysis and co-chromatography with authentic sugars. These 
emphasized that this compound was identified as quercetin-7-O-
arabinoside-3-O-neohesperidosides.
   Compound 2 showed purple spot when examined under UV at 
λ 365 nm, suggesting substituted 3 hydroxyl group, which was 
confirmed by UV-shift reagents. The 1H-NMRδ showed the expected 
signal in the aromatic region for -3-O- substituted quercetin, signals 
of two anomeric protons of sugar doublet at δH 5.2 (J = 7.65 Hz) 
and 5.3 (J = 6.85 Hz); their coupling constants matched the values 
of β-D-glucopyranoside and α-L-arabinopyranoside, respectively[21-
23]. This was confirmed by the observed two anomeric carbon of 
sugar at 101.3 and 103.2 ppm in 13C-NMRδ and the appearance of 
molecular ions in ESI/MS at m/z 595 [M-H]- and fragment ion at 
m/z 301 [M-H-294]- due to loss of hexose and pentose units. Acid 
hydrolysis indicated the presence of glucose and arabinose. The 
13C-NMR spectra showed significant down field shift of 6 ppm for
the C6 signal of glucose due to interglycosidic linkage indicating 
that the glucopyranoside unit directly attached to the aglycone and 
arabinopyranoside was a terminal sugar. Altogether, compound 2 
was identified as quercetin 3-O-α-L-arabinopyranosyl(1'''→6'')-β-D-
glucopyranoside[26].
   For compound 3, the MS, 1H-NMR and 13C-NMR data were in 
agreement with those reported for quercetin-3-O-glucopyranoside-7-
O-rhamnopyranoside[27].
   In the situation of compound 4, the UV absorbance of compound 
with shift reagents indicated a flavonol moiety substituted at C7 
and C3. ESI/MS of compound 4 showed a mass molecular ion at m/
z 595 [M-H]-. The MS2 fragment ion at m/z 463 [M-H-132]- was 
corresponding to the loss pentose moiety. Further, MS3 fragment 
ion was observed at m/z 301 [M-H-132-162]- indicating the loss of 
a hexose unit. The sugars were identified by acid hydrolysis and co-
chromatography with authentic sugars, arabinose and glucose. The 
intensity of the fragment resulting from loss of hexose was higher 
than that obtained from loss of pentose, indicating glucose attached 
to C3 meanwhile arabinose was at C7. The compound was identified 
as quercetin-3-O- glucoside,7-O-arabinoside[25].
   For compound 5, all data were in accordance with those of apigenin-
6-C-glucopyranoside-8-C-arabinopyranoside (schaftoside)[28].
   For compound 6, chemical shifts values at δH6.44 for H-6, δH 6.81 for 
H-8, δc 147.9 (C-2) and δc 160.1 for (C-7) suggested 7-O-glycosylated 
flavonoids, while anomeric proton at δ 5.10 with J = 7.7 Hz indicated 
the β configuration. Results of UV, MS, 1H-NMR and 13C-NMR were in 
agreement with those previously reported in the literature of quercetin-
7-O-glucopyranoside (quercimeritrin)[21-23].
   For compound 7, the UV, ESIMS, 1H-NMR results were 
corresponding to those of isorhamnetin-3-O-glucoside[21-23].
   For compound 8, ESIMS and 1H-NMR results matched those 
reported to quercetin[21-23].
3.2. HPLC of phenolic acid fraction
   HPLC analysis of phenolic acid fraction led to identification of five 
compounds which were compiled in Table 1. Ellagic acid (26.4%) 
and cathechin (31.3%) were predominant ones.
Table 1
HPLC analysis of phenolic acids.
Compounds Retention time (min) Relative (%)
Gallic acid   3.00   5.3
Caffeic acid   3.50 15.4
Ellagic acid   4.00 26.4
Cathechin   6.90 31.3
Coumaric acid      11.17 21.1
3.3. Antiplasmodial and cytotoxic activities
   The antiplasmodial effect of tested extracts and compounds 
against P. falciparum was expressed as concentration that killed 
50% of parasites (IC50) in Table 2. All extracts possessed moderate 
lethal effect IC50 ranging from 10 to 50 μg/mL. Among the tested 
flavonoids, compound 8 (IC50 = 9 μg/mL) was the most potent followed 
by compound 6 then compound 2 and finally compound 3. Extracts 
exhibited cytotoxicity with 50% cytotoxicity concentration (CC50) 
values ranging from 27–33 µg/mL on the mammalian MCF-7 cell line.
Table 2
Antiplasmodial activity and cytotoxicity of A. lindleyi extracts and some 
isolated compounds.
Sample IC50
a ± SD (μg/mL) CC50 ± SD (μg/mL)
b Selectivity indexc 
FcB1 strain MCF-7 MCF-7/FcB1
Pet ether extract      33 27.00    0.82
Chloroform extract 28.500 0 ± 0.500 0 32.00    1.02
Ethanol extract 33.000 0 ± 1.000 0 30.00     0.91
Compound 2      63 Not tested -
Compound 3 > 100 Not tested -
Compound 6 33 Not tested -
Compound 8       9 Not tested -
Chloroquine 
(n = 5)
0.072 0 ± 0.015 0   9.70   134.00
Sodium artesunate  0.002 4 ± 0.001 2c    3.97d 1 654.00
Values were expressed as mean percentage of three replication ± SD; a: 
Drug concentration that killed 50% of FcB1 strain; b: Drug concentration 
(CC50) needed to cause 50% decrease of the cellular viability of MCF-7; 
c: 
Cytotoxicity/antiplasmodial activity ratio; d: Nepveu et al., 2010[29].
3.4. Antimicrobial activity
   The antimicrobial activities were summarized in Table 3. The 
results showed that extracts demonstrated antibacterial activity with 
MIC and MBC ranging from 62–125 µg/mL and 125–500 µg/mL, 
respectively, exhibiting similar inhibitory effect on E. hirae and 
other three germs. Petroleum ether and chloroform extracts were 
more active on P. aeruginosa than reference drugs (nalidixic acid, 
bifonazole, clotrimazole). 
   Meanwhile, petroleum ether and aqueous ethanol extracts 
exhibited antimicrobial activity against S. aureus similar to 
reference drugs. On the other hand, all the extracts showed the same 
antifungal effect on the tested fungi. The yeast C. albicans was 
more susceptible to the extracts with MIC values of 62.5 µg/mL.   
3.5. Radical scavenging ability 
   The IC50 of extracts in DPPH absorbance represented in Table 4 
revealed that the petroleum ether extract had no radical scavenging 
ability at the tested concentration.
Table 4
The DPPH radical scavenging activity (IC50) of the extracts compared with 
vitamin C and Trolox as standard antioxidants. 
Sample IC50
a (mg/L) ± SD
Pet ether extract > 667
Chloroform extract   332.46 ± 16.21
Ethanol extract 345.70 ± 2.77
Trolox     8.36 ± 0.05
Ascorbic acid     3.80 ± 0.08
Each value was expresssed as mean percentage of three replication ± SD; a: 
Concentration that inhibited DPPH absorbance by 50%.
4. Discussion
In spite of extensive studies, the structure-activity relationships
for the antiplasmodial action remain unclear. Here we found that the 
hydrophilic extract which comprises predominantly flavonoids and 
phenolic acids showed radical scavenging ability and antiplasmodial 
activity. Our detailed investigation of the isolated compounds used 
as antiplasmodial showed that the aglycone with free hydroxyl 
groups was the most active compound and its activity decreased 
upon the substitution of hydroxyl groups. We also observed that 
the 7-O-subtituted flavonol was relatively more active than 3-O-
subtituted and that the disubstitution at 7-O and 3-O was unfavorable 
to the antiplasmodial activity. From our data, it can be concluded 
that the free OH considerably increased the antiplasmodial activity, 
which is reduced when the free OH is occupied by sugar moiety. 
These results are supported by an earlier study[30], which focused on 
the efficacy of different flavonoids and gallic acid esters of catechins 
toward three important enzymes, i.e. β-ketoacyl-ACP-reductase, 
β-hydroxacyl-ACP-dehydratase and enoyl-ACP-reductase involved in 
the fatty acid biosynthesis of P. falciparum strain. The authors found 
that the activity of flavonoids was attributed to the combination 
of two (catechol) or three hydroxyl group in ring B (regardless of 
an additional hydroxyl group at C-3). They also reported that the 
presence of the double bond between C-2 and C-3 was essential to 
keep the planarity structure of flavonoids with respect to activity. 
Another study found that a bulky substituent such as sugar moiety 
at C-3 of flavonol forced the ring B out of the plane of the AC-
ring[31]. These studies explained why compound 6 was relatively 
active compared to compound 2 while compound 3 was inactive. 
These results are in agreement with those deduced by Moalin et 
al. regarding the antioxidant capacity of quercetin derivatives[31]. 
Another parameter is the oxidative stress which is considered 
beneficial for killing parasites and for weakening the adherence 
between infected RBCs and endothelial cells or monocytes. It was 
reported that compounds with high oxidation potential may be used 
as relatively efficient antiplasmodial agents with low mammalian cell 
cytotoxicity[32]. In our study, both chloroform and ethanol extracts 
displayed higher radical scavenging ability, antiplasmodial activity 
and lower cytotoxicity than petroleum ether extract. In contrast, 
the petroleum ether extract showed no radical scavenging ability, 
relatively lower antiplasmodial activity and higher cytotoxicity than 
the ethanol extract. The constituents of petroleum ether extract have 
been recently studied for their hepatorenal protection and cytotoxic 
effects[16]. Despite of the limited antimicrobial activity of extracts, 
it is noteworthy that P. aeruginosa and C. albicans were the most 
susceptible microorganisms. Particularly, both organisms are 
frequently coexisting opportunistic pathogens, forming microbial 
biofilms that can lead to severe illness and serious threat to human 
health[33].
   To the best of our knowledge, this is the first study to investigate 
the possible antimalarial effect of A. lindleyi extracts. Evaluating the 
extracts and compounds revealed promising antiplasmodial activity 
of ethanol extract and some components. Moreover, this plant can 
be useful as prophylactic against C. albicans and P. aeruginosa. 
The identified compounds were reported for the first time from this 
species excluding compounds 7 and 8.
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